Celastrol
Spécifications
34157-83-0Numéro CAS
636-472-5Numéro CE
(2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acidNom IUPAC
C29H38O4Formule chimique
450.6 g/molMasse molaire
celastrol; 34157-83-0; Tripterin; Tripterine; (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid; (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid; L8GG98663L; NSC-70931; DTXSID2040993; CHEBI:63959; D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20alpha)-; 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid; RefChem:124284; DTXCID0020993; MFCD03424073; Celastrol (>85%); NSC70931; 3-hydroxy-9beta,13alpha-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid; 2-Oxo-3-hydroxy-24-norfriedelane-1(10),3,5,7-tetraene-29-oic acid; SR-05000002679; MLS002701906; NSC 70931; UNII-L8GG98663L; Celastrol?; 34157-83-0 (castrol); Celastrol,Tripterin; Celastrol (Standard); Spectrum_000335; Pristimerin (Celastrol); CELASTROL [MI]; Spectrum2_000150; Spectrum3_000233; Spectrum4_001966; Spectrum5_000805; SCHEMBL14954; BSPBio_001905; KBioGR_002436; KBioSS_000815; SPECTRUM201664; MLS006011086; DivK1c_000718; SPBio_000260; orb1304608; orb3140252; GTPL10386; KBio1_000718; KBio2_000815; KBio2_003383; KBio2_005951; KBio3_001405; NINDS_000718; BDBM205457; GLXC-02518; HMS1923A13; HMS3649E12; HMS3884G09; HMS6019F07; EX-A7823; CCG-39919; EBC-11155; HB4605; HY-13067R; MSK157285; s1290; Celastrol, >=98% (HPLC), solid; AKOS025311497; AC-6031; compound 2 [PMID: 28621943]; CS-0409; FC19885; GS-6082; IDI1_000718; NCGC00178913-01; NCGC00178913-02; NCGC00178913-04; NCGC00178913-05; NCGC00178913-10; NCGC00178913-14; NCGC00178913-15; HY-13067; NCI60_038570; SMR004702874; SY028490; C1844; C2737; H10498; AK-693/21141017; Q5057534; SR-05000002679-1; SR-05000002679-3; SR-05000002679-4; (20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oate; (20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid; 24-NOR-D:A-FRIEDOOLEANA-1(10),3,5,7-TETRAEN-29-OIC ACID, 3-HYDROXY-2-OXO-; 3-Hydroxy-2-oxo-24-nor-D:A-friedooleana-1(10),3,5,7-tetraen-29-oic acid; (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylicacid; (2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-2-picenecarboxylic acid; (9b,13a,14b,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24, 25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid; 1,2,3,4,4a,5,6,6a, 11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b, 14a-hexamethyl-11-oxo-2-Picenecarboxylic acid; 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)-; 2-Picenecarboxylic acid,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-; 24,25,26-TRINOROLEANA-1(10),3,5,7-TETRAEN-29-OIC ACID, 3-HYDROXY-9,13-DIMETHYL-2-OXO-, (9.BETA.,13.ALPHA.,14.BETA.,20.ALPHA.)-; 3-Hydroxy-9.beta.,13.alpha.-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acidSynonymes
